Mulder RH, Neumann A, Cecil CAM, Walton E, Houtepen LC, Simpkin AJ, et al
Methods Study design and procedures This was a phase 1, randomised, placebo-controlled, double-blind, combined single ascending dose (Part A) and multiple ascending dose (Part B) study conducted in overweight or obese participants with type 2 diabetes (ClinicalTrials.gov registration no
Warning signs include medication sold without a genuine provider evaluation, unclear or hidden licensing, no follow-up support, and pricing that is difficult to find
Most guidance points to stopping GLP-1 medications at least two months before you actively try to conceive, since these drugs can linger in your system for weeks (University Hospitals)